质母细胞瘤突变改变了EGFR二分体结构,以防止连接物偏差
Chun Hu1,2, Carlos A Leche1,2, Anatoly Kiyatkin1,2
1Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.
Nature
|February 10, 2022
概括
在表皮生长因子受体 (EGFR) 中的质母细胞突变损害了其区分激活配体的能力. 这种由EGFR改变的配体分离有助于癌症的发展,并可能提供新的治疗点.
科学领域:
- 癌症学
- 分子生物学
- 生物化学
背景情况:
- 皮肤生长因子受体 (EGFR) 突变在人类癌症中很常见,是关键的治疗点.
- 由于突变位置的差异,EGFR抑制剂在肺癌中有效,但在多种质母细胞瘤 (GBM) 中不有效.
- 与肺癌相比,与GBM相关的EGFR突变发生在细胞外领域.
研究的目的:
- 研究细胞外GBM突变如何影响EGFR对其激活配体的反应.
- 阐明GBM突变改变EGFR二分化和信号的结构机制.
- 探索改变EGFR连接体对GBM病变和治疗的影响.
主要方法:
- 在存在GBM突变时进行细胞测试以评估EGFR连体差异化.
- 用X射线结晶学来确定改变EGFR二分化的结构基础.
- 分析各种EGFR配体诱导的差异信号动力学.
主要成果:
- 常见的细胞外GBM突变使EGFR无法有效地区分EGF和epiregulin (EREG).
- 突变的EGFR在对EREG等低亲缘关系联体的反应中形成强烈的EGF类二元体.
- 结构分析显示,R84K突变对称了EREG诱导的二元体,而A265V则强化了不对称的二元体.
结论:
- 改变EGFR对连体的区分是质母细胞瘤发展的一个重要因素.
- 了解这些分子机制可以了解治疗耐药性和潜在的新治疗策略.
- 针对由连接体结合缺陷驱动的异常EGFR信号可能是对GBM的有希望的治疗方法.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.9K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.3K
相关概念视频
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Enzyme-linked Receptors
80.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.4K
Receptor Tyrosine Kinases
14.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.8K
